Novel motif:90: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:00, 9 September 2013
name: | motif90_TTATATCGC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0022614 | membrane to membrane docking | 2.993898e-13 |
GO:0048806 | genitalia development | 2.163844e-10 |
GO:0021568 | rhombomere 2 development | 2.417592e-10 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 2.699730e-10 |
GO:0021930 | cerebellar granule cell precursor proliferation | 2.596228e-9 |
GO:0043570 | maintenance of DNA repeat elements | 9.643254e-9 |
GO:0009107 | lipoate biosynthetic process | 1.259615e-8 |
GO:0007598 | blood coagulation, extrinsic pathway | 5.683842e-8 |
GO:0007016 | cytoskeletal anchoring at plasma membrane | 9.226772e-8 |
GO:0039020 | pronephric nephron tubule development | 1.074830e-7 |
GO:0035565 | regulation of pronephros size | 1.074830e-7 |
GO:0006266 | DNA ligation | 2.269627e-7 |
GO:0035112 | genitalia morphogenesis | 4.394819e-7 |
GO:0006437 | tyrosyl-tRNA aminoacylation | 4.464810e-7 |
GO:0021546 | rhombomere development | 4.977584e-7 |
GO:0032673 | regulation of interleukin-4 production | 5.258215e-7 |
GO:0009106 | lipoate metabolic process | 5.566230e-7 |
GO:0072181 | mesonephric duct formation | 6.014399e-7 |
GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 6.136235e-7 |
GO:0022406 | membrane docking | 1.042586e-6 |
GO:0008272 | sulfate transport | 1.553967e-6 |
GO:0019319 | hexose biosynthetic process | 2.274211e-6 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 2.634765e-6 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 3.042444e-6 |
GO:0006094 | gluconeogenesis | 3.180763e-6 |
GO:0035411 | catenin import into nucleus | 4.061677e-6 |
GO:0072172 | mesonephric tubule formation | 4.563706e-6 |
GO:0015074 | DNA integration | 4.914912e-6 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 5.820170e-6 |
GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 5.985156e-6 |
GO:0032252 | secretory granule localization | 6.582915e-6 |
GO:0043111 | replication fork arrest | 7.085530e-6 |
GO:0061017 | hepatoblast differentiation | 8.037618e-6 |
GO:0051254 | positive regulation of RNA metabolic process | 8.566944e-6 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 9.455542e-6 |
GO:0046364 | monosaccharide biosynthetic process | 1.010975e-5 |
GO:0030902 | hindbrain development | 1.012754e-5 |
GO:0061384 | heart trabecular morphogenesis | 1.054265e-5 |
GO:0072095 | regulation of branch elongation involved in ureteric bud branching | 1.260033e-5 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 1.306279e-5 |
GO:0060216 | definitive hemopoiesis | 1.658848e-5 |
GO:0044334 | canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition | 1.791305e-5 |
GO:0010909 | positive regulation of heparan sulfate proteoglycan biosynthetic process | 1.791305e-5 |
GO:0019047 | provirus integration | 2.092439e-5 |
GO:0061383 | trabecula morphogenesis | 2.122545e-5 |
GO:0090304 | nucleic acid metabolic process | 2.204447e-5 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 2.388888e-5 |
GO:0030194 | positive regulation of blood coagulation | 2.701980e-5 |
GO:0032743 | positive regulation of interleukin-2 production | 3.037183e-5 |
GO:0006259 | DNA metabolic process | 3.396422e-5 |
GO:0048265 | response to pain | 3.436506e-5 |
GO:0007159 | leukocyte cell-cell adhesion | 3.660239e-5 |
GO:0001826 | inner cell mass cell differentiation | 3.708568e-5 |
GO:0070265 | necrotic cell death | 3.786744e-5 |
GO:0000726 | non-recombinational repair | 3.966042e-5 |
GO:0040019 | positive regulation of embryonic development | 3.975786e-5 |
GO:0031328 | positive regulation of cellular biosynthetic process | 4.095365e-5 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 4.295199e-5 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 4.328907e-5 |
GO:0002543 | activation of blood coagulation via clotting cascade | 4.664888e-5 |
GO:0051176 | positive regulation of sulfur metabolic process | 4.858305e-5 |
GO:0048566 | embryonic digestive tract development | 5.056661e-5 |
GO:0050820 | positive regulation of coagulation | 5.148215e-5 |
GO:0032571 | response to vitamin K | 5.209259e-5 |
GO:0010628 | positive regulation of gene expression | 5.245613e-5 |
GO:0051386 | regulation of nerve growth factor receptor signaling pathway | 5.247605e-5 |
GO:0051447 | negative regulation of meiotic cell cycle | 5.793983e-5 |
GO:0048388 | endosomal lumen acidification | 5.801399e-5 |
GO:0042762 | regulation of sulfur metabolic process | 5.815140e-5 |
GO:0060554 | induction of necroptosis of activated-T cells | 5.915315e-5 |
GO:0072171 | mesonephric tubule morphogenesis | 6.097032e-5 |
GO:0060437 | lung growth | 6.166334e-5 |
GO:0072378 | blood coagulation, fibrin clot formation | 6.448045e-5 |
GO:0032753 | positive regulation of interleukin-4 production | 6.551034e-5 |
GO:0009891 | positive regulation of biosynthetic process | 6.553392e-5 |
GO:0006139 | nucleobase-containing compound metabolic process | 7.968575e-5 |
GO:0009949 | polarity specification of anterior/posterior axis | 8.024269e-5 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 8.024269e-5 |
GO:0034633 | retinol transport | 8.204534e-5 |
GO:0044029 | hypomethylation of CpG island | 9.389291e-5 |
GO:2000121 | regulation of removal of superoxide radicals | 9.621274e-5 |
GO:0030538 | embryonic genitalia morphogenesis | 9.647930e-5 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 1.053612e-4 |
GO:0046666 | retinal cell programmed cell death | 1.107759e-4 |
GO:0003222 | ventricular trabecular myocardium morphogenesis | 1.107759e-4 |
GO:0006734 | NADH metabolic process | 1.190933e-4 |
GO:0048562 | embryonic organ morphogenesis | 1.218305e-4 |
GO:0048557 | embryonic digestive tract morphogenesis | 1.254395e-4 |
GO:0048625 | myoblast cell fate commitment | 1.301352e-4 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 1.326272e-4 |
GO:0030259 | lipid glycosylation | 1.458310e-4 |
GO:0002726 | positive regulation of T cell cytokine production | 1.582258e-4 |
GO:0002691 | regulation of cellular extravasation | 1.582258e-4 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 1.633605e-4 |
GO:0071506 | cellular response to mycophenolic acid | 1.633605e-4 |
GO:0048641 | regulation of skeletal muscle tissue development | 1.661906e-4 |
GO:0031295 | T cell costimulation | 1.668967e-4 |
GO:0030317 | sperm motility | 1.851441e-4 |
GO:0001714 | endodermal cell fate specification | 1.858817e-4 |
GO:0032892 | positive regulation of organic acid transport | 1.987585e-4 |
GO:0006560 | proline metabolic process | 2.261320e-4 |
GO:0046165 | alcohol biosynthetic process | 2.338756e-4 |
GO:0009822 | alkaloid catabolic process | 2.427929e-4 |
GO:0060337 | type I interferon-mediated signaling pathway | 2.577829e-4 |
GO:0072180 | mesonephric duct morphogenesis | 2.623482e-4 |
GO:0048266 | behavioral response to pain | 2.646364e-4 |
GO:0046827 | positive regulation of protein export from nucleus | 2.710778e-4 |
GO:0016202 | regulation of striated muscle tissue development | 2.715354e-4 |
GO:0030193 | regulation of blood coagulation | 2.722647e-4 |
GO:0034340 | response to type I interferon | 2.777516e-4 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 2.882369e-4 |
GO:0048619 | embryonic hindgut morphogenesis | 2.925771e-4 |
GO:0006072 | glycerol-3-phosphate metabolic process | 2.986457e-4 |
GO:0019362 | pyridine nucleotide metabolic process | 3.212895e-4 |
GO:0021986 | habenula development | 3.262668e-4 |
GO:0050818 | regulation of coagulation | 3.302671e-4 |
GO:0045453 | bone resorption | 3.304975e-4 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 3.322891e-4 |
GO:0032024 | positive regulation of insulin secretion | 3.429725e-4 |
GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport | 3.719344e-4 |
GO:0070498 | interleukin-1-mediated signaling pathway | 3.723332e-4 |
GO:0021903 | rostrocaudal neural tube patterning | 3.723332e-4 |
GO:0072110 | glomerular mesangial cell proliferation | 4.013200e-4 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 4.013200e-4 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 4.025345e-4 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 4.115080e-4 |
GO:2000124 | regulation of endocannabinoid signaling pathway | 4.290186e-4 |
GO:0007600 | sensory perception | 4.339788e-4 |
GO:0034337 | RNA folding | 4.581333e-4 |
GO:0048634 | regulation of muscle organ development | 4.699463e-4 |
GO:0016070 | RNA metabolic process | 5.116299e-4 |
GO:0006561 | proline biosynthetic process | 5.207971e-4 |
GO:0023019 | signal transduction involved in regulation of gene expression | 5.290076e-4 |
GO:0090004 | positive regulation of establishment of protein localization in plasma membrane | 5.534183e-4 |
GO:0051387 | negative regulation of nerve growth factor receptor signaling pathway | 5.737856e-4 |
GO:0045047 | protein targeting to ER | 5.833206e-4 |
GO:0019233 | sensory perception of pain | 5.969380e-4 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 6.139282e-4 |
GO:0046496 | nicotinamide nucleotide metabolic process | 6.210040e-4 |
GO:0035284 | brain segmentation | 6.651919e-4 |
GO:0002724 | regulation of T cell cytokine production | 6.891768e-4 |
GO:0072177 | mesonephric duct development | 7.055460e-4 |
GO:0072109 | glomerular mesangium development | 7.055460e-4 |
GO:0060343 | trabecula formation | 7.212269e-4 |
GO:0001711 | endodermal cell fate commitment | 7.266696e-4 |
GO:0035883 | enteroendocrine cell differentiation | 7.304781e-4 |
GO:0032913 | negative regulation of transforming growth factor beta3 production | 7.304781e-4 |
GO:0032600 | chemokine receptor transport out of membrane raft | 7.304781e-4 |
GO:0032597 | B cell receptor transport into membrane raft | 7.304781e-4 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 7.508296e-4 |
GO:0044030 | regulation of DNA methylation | 7.714754e-4 |
GO:0003329 | pancreatic PP cell fate commitment | 7.768772e-4 |
GO:0003326 | pancreatic A cell fate commitment | 7.768772e-4 |
GO:2000774 | positive regulation of cellular senescence | 8.217453e-4 |
GO:0035986 | senescence-associated heterochromatin focus formation | 8.217453e-4 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 8.219582e-4 |
GO:0043588 | skin development | 8.977047e-4 |
GO:0032733 | positive regulation of interleukin-10 production | 9.128491e-4 |
GO:0045995 | regulation of embryonic development | 9.215227e-4 |
GO:0051155 | positive regulation of striated muscle cell differentiation | 9.350912e-4 |
GO:0045597 | positive regulation of cell differentiation | 9.432026e-4 |
GO:0007225 | patched ligand maturation | 9.736953e-4 |
GO:0002052 | positive regulation of neuroblast proliferation | 9.770540e-4 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 9.776562e-4 |
GO:0050850 | positive regulation of calcium-mediated signaling | 9.861123e-4 |
GO:0051053 | negative regulation of DNA metabolic process | 9.939254e-4 |
GO:0043624 | cellular protein complex disassembly | 9.972774e-4 |
GO:0016525 | negative regulation of angiogenesis | 1.018429e-3 |
GO:0048568 | embryonic organ development | 1.044305e-3 |
GO:0019674 | NAD metabolic process | 1.047546e-3 |
GO:0019441 | tryptophan catabolic process to kynurenine | 1.063827e-3 |
GO:0000710 | meiotic mismatch repair | 1.065773e-3 |
GO:0031016 | pancreas development | 1.066076e-3 |
GO:0021512 | spinal cord anterior/posterior patterning | 1.175202e-3 |
GO:0006425 | glutaminyl-tRNA aminoacylation | 1.175202e-3 |
GO:0007113 | endomitotic cell cycle | 1.175202e-3 |
GO:0002200 | somatic diversification of immune receptors | 1.183685e-3 |
GO:0016558 | protein import into peroxisome matrix | 1.239382e-3 |
GO:0050796 | regulation of insulin secretion | 1.287398e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 1.293517e-3 |
GO:0033151 | V(D)J recombination | 1.302459e-3 |
GO:0021511 | spinal cord patterning | 1.310945e-3 |
GO:0046321 | positive regulation of fatty acid oxidation | 1.327486e-3 |
GO:0060347 | heart trabecula formation | 1.335297e-3 |
GO:0042118 | endothelial cell activation | 1.344950e-3 |
GO:0035564 | regulation of kidney size | 1.344950e-3 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 1.364680e-3 |
GO:0060743 | epithelial cell maturation involved in prostate gland development | 1.391744e-3 |
GO:0051276 | chromosome organization | 1.417798e-3 |
GO:0009744 | response to sucrose stimulus | 1.422015e-3 |
GO:0035987 | endodermal cell differentiation | 1.440505e-3 |
GO:0042663 | regulation of endodermal cell fate specification | 1.483037e-3 |
GO:0043241 | protein complex disassembly | 1.485650e-3 |
GO:0042254 | ribosome biogenesis | 1.487250e-3 |
GO:0045213 | neurotransmitter receptor metabolic process | 1.500976e-3 |
GO:0042574 | retinal metabolic process | 1.560255e-3 |
GO:0070189 | kynurenine metabolic process | 1.608586e-3 |
GO:0046621 | negative regulation of organ growth | 1.608586e-3 |
GO:0060249 | anatomical structure homeostasis | 1.612451e-3 |
GO:0010867 | positive regulation of triglyceride biosynthetic process | 1.631275e-3 |
GO:0032774 | RNA biosynthetic process | 1.654739e-3 |
GO:0045444 | fat cell differentiation | 1.671366e-3 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 1.709339e-3 |
GO:0034968 | histone lysine methylation | 1.723625e-3 |
GO:0034261 | negative regulation of Ras GTPase activity | 1.738891e-3 |
GO:0031117 | positive regulation of microtubule depolymerization | 1.739763e-3 |
GO:0033555 | multicellular organismal response to stress | 1.788468e-3 |
GO:0034770 | histone H4-K20 methylation | 1.788758e-3 |
GO:0030509 | BMP signaling pathway | 1.818085e-3 |
GO:0021532 | neural tube patterning | 1.820457e-3 |
GO:0032663 | regulation of interleukin-2 production | 1.879829e-3 |
GO:2000193 | positive regulation of fatty acid transport | 1.936305e-3 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 1.953662e-3 |
GO:0090277 | positive regulation of peptide hormone secretion | 1.953969e-3 |
GO:0031018 | endocrine pancreas development | 1.957743e-3 |
GO:0006732 | coenzyme metabolic process | 1.989421e-3 |
GO:2000438 | negative regulation of monocyte extravasation | 1.990116e-3 |
GO:0080154 | regulation of fertilization | 1.990116e-3 |
GO:0035724 | CD24 biosynthetic process | 1.990116e-3 |
GO:0035723 | interleukin-15-mediated signaling pathway | 1.990116e-3 |
GO:0009108 | coenzyme biosynthetic process | 2.019467e-3 |
GO:0034637 | cellular carbohydrate biosynthetic process | 2.022901e-3 |
GO:2000111 | positive regulation of macrophage apoptosis | 2.049177e-3 |
GO:0045722 | positive regulation of gluconeogenesis | 2.075251e-3 |
GO:0045445 | myoblast differentiation | 2.097345e-3 |
GO:0010832 | negative regulation of myotube differentiation | 2.141310e-3 |
GO:0002793 | positive regulation of peptide secretion | 2.142693e-3 |
GO:0045165 | cell fate commitment | 2.168620e-3 |
GO:0006984 | ER-nucleus signaling pathway | 2.174828e-3 |
GO:0061041 | regulation of wound healing | 2.175062e-3 |
GO:0050927 | positive regulation of positive chemotaxis | 2.186500e-3 |
GO:0048808 | male genitalia morphogenesis | 2.236424e-3 |
GO:0010467 | gene expression | 2.241927e-3 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 2.285089e-3 |
GO:0051017 | actin filament bundle assembly | 2.294073e-3 |
GO:0060677 | ureteric bud elongation | 2.334576e-3 |
GO:0060325 | face morphogenesis | 2.345463e-3 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 2.357976e-3 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 2.377924e-3 |
GO:0008633 | activation of pro-apoptotic gene products | 2.378338e-3 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.409286e-3 |
GO:0002669 | positive regulation of T cell anergy | 2.435820e-3 |
GO:0034341 | response to interferon-gamma | 2.444394e-3 |
GO:0048743 | positive regulation of skeletal muscle fiber development | 2.458519e-3 |
GO:0014003 | oligodendrocyte development | 2.476231e-3 |
GO:0019083 | viral transcription | 2.488006e-3 |
GO:0071845 | cellular component disassembly at cellular level | 2.534414e-3 |
GO:2000026 | regulation of multicellular organismal development | 2.549968e-3 |
GO:0071398 | cellular response to fatty acid | 2.552127e-3 |
GO:0032274 | gonadotropin secretion | 2.647812e-3 |
GO:0051096 | positive regulation of helicase activity | 2.663626e-3 |
GO:0001704 | formation of primary germ layer | 2.721209e-3 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 2.783111e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 2.818370e-3 |
GO:0006006 | glucose metabolic process | 2.820675e-3 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 2.892646e-3 |
GO:0072111 | cell proliferation involved in kidney development | 2.920285e-3 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 2.925510e-3 |
GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation | 2.934032e-3 |
GO:0032066 | nucleolus to nucleoplasm transport | 2.934032e-3 |
GO:0045900 | negative regulation of translational elongation | 2.934032e-3 |
GO:0010720 | positive regulation of cell development | 2.987713e-3 |
GO:2000109 | regulation of macrophage apoptosis | 2.990402e-3 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.029783e-3 |
GO:0050926 | regulation of positive chemotaxis | 3.038750e-3 |
GO:0007442 | hindgut morphogenesis | 3.076151e-3 |
GO:0022411 | cellular component disassembly | 3.144897e-3 |
GO:0031507 | heterochromatin formation | 3.179207e-3 |
GO:0042416 | dopamine biosynthetic process | 3.299813e-3 |
GO:0001894 | tissue homeostasis | 3.301354e-3 |
GO:0065001 | specification of axis polarity | 3.319274e-3 |
GO:0030644 | cellular chloride ion homeostasis | 3.319274e-3 |
GO:0006144 | purine base metabolic process | 3.330372e-3 |
GO:0071285 | cellular response to lithium ion | 3.330852e-3 |
GO:0090322 | regulation of superoxide metabolic process | 3.374041e-3 |
GO:0051318 | G1 phase | 3.376965e-3 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 3.405241e-3 |
GO:0050793 | regulation of developmental process | 3.430950e-3 |
GO:0042074 | cell migration involved in gastrulation | 3.486404e-3 |
GO:0003406 | retinal pigment epithelium development | 3.493069e-3 |
GO:0060555 | induction of necroptosis by extracellular signals | 3.498841e-3 |
GO:0001763 | morphogenesis of a branching structure | 3.527335e-3 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 3.573132e-3 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 3.590116e-3 |
GO:0032148 | activation of protein kinase B activity | 3.683821e-3 |
GO:0006925 | inflammatory cell apoptosis | 3.684891e-3 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 3.721832e-3 |
GO:0051252 | regulation of RNA metabolic process | 3.767289e-3 |
GO:0090273 | regulation of somatostatin secretion | 3.769708e-3 |
GO:0055119 | relaxation of cardiac muscle | 3.769708e-3 |
GO:0030219 | megakaryocyte differentiation | 3.769708e-3 |
GO:0090276 | regulation of peptide hormone secretion | 3.822260e-3 |
GO:0008078 | mesodermal cell migration | 3.877533e-3 |
GO:0018130 | heterocycle biosynthetic process | 3.913590e-3 |
GO:0006415 | translational termination | 3.952666e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 3.964552e-3 |
GO:0030258 | lipid modification | 3.983065e-3 |
GO:0006071 | glycerol metabolic process | 4.040402e-3 |
GO:0072321 | chaperone-mediated protein transport | 4.076875e-3 |
GO:0040009 | regulation of growth rate | 4.112934e-3 |
GO:0051939 | gamma-aminobutyric acid import | 4.182612e-3 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 4.182612e-3 |
GO:0048871 | multicellular organismal homeostasis | 4.207583e-3 |
GO:0019058 | viral infectious cycle | 4.272234e-3 |
GO:0090343 | positive regulation of cell aging | 4.288431e-3 |
GO:0051896 | regulation of protein kinase B signaling cascade | 4.350883e-3 |
GO:0006885 | regulation of pH | 4.358537e-3 |
GO:0060323 | head morphogenesis | 4.401974e-3 |
GO:0007605 | sensory perception of sound | 4.419853e-3 |
GO:0016071 | mRNA metabolic process | 4.431439e-3 |
GO:0007411 | axon guidance | 4.561580e-3 |
GO:0019318 | hexose metabolic process | 4.580014e-3 |
GO:0021915 | neural tube development | 4.604407e-3 |
GO:0090003 | regulation of establishment of protein localization in plasma membrane | 4.640842e-3 |
GO:0090399 | replicative senescence | 4.684584e-3 |
GO:0019059 | initiation of viral infection | 4.711766e-3 |
GO:0031954 | positive regulation of protein autophosphorylation | 4.747048e-3 |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 4.851085e-3 |
GO:0045746 | negative regulation of Notch signaling pathway | 4.862859e-3 |
GO:0045039 | protein import into mitochondrial inner membrane | 4.943364e-3 |
GO:0008625 | induction of apoptosis via death domain receptors | 4.944944e-3 |
GO:0072594 | establishment of protein localization to organelle | 4.974941e-3 |
GO:0010477 | response to sulfur dioxide | 4.989389e-3 |
GO:0002457 | T cell antigen processing and presentation | 4.989389e-3 |
GO:0055118 | negative regulation of cardiac muscle contraction | 5.021740e-3 |
GO:0051253 | negative regulation of RNA metabolic process | 5.157867e-3 |
GO:0051103 | DNA ligation involved in DNA repair | 5.177785e-3 |
GO:0002791 | regulation of peptide secretion | 5.241044e-3 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 5.419527e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 5.495831e-3 |
GO:0042659 | regulation of cell fate specification | 5.511884e-3 |
GO:2000772 | regulation of cellular senescence | 5.576636e-3 |
GO:0051024 | positive regulation of immunoglobulin secretion | 5.746978e-3 |
GO:0043497 | regulation of protein heterodimerization activity | 5.812771e-3 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 5.829736e-3 |
GO:0000073 | spindle pole body separation | 5.861633e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 5.925375e-3 |
GO:0070995 | NADPH oxidation | 5.940590e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 5.946478e-3 |
GO:0001958 | endochondral ossification | 6.070356e-3 |
GO:0051095 | regulation of helicase activity | 6.189674e-3 |
GO:0070972 | protein localization in endoplasmic reticulum | 6.333418e-3 |
GO:0006639 | acylglycerol metabolic process | 6.417692e-3 |
GO:0019227 | neuronal action potential propagation | 6.461684e-3 |
GO:0034284 | response to monosaccharide stimulus | 6.511795e-3 |
GO:0071346 | cellular response to interferon-gamma | 6.599815e-3 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 6.628428e-3 |
GO:0043524 | negative regulation of neuron apoptosis | 6.723146e-3 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 6.741498e-3 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 6.777915e-3 |
GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I | 6.798107e-3 |
GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent | 6.798107e-3 |
GO:0002481 | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent | 6.798107e-3 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 6.798107e-3 |
GO:0034332 | adherens junction organization | 6.831915e-3 |
GO:2000278 | regulation of DNA biosynthetic process | 6.895185e-3 |
GO:0031327 | negative regulation of cellular biosynthetic process | 6.895757e-3 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 6.921341e-3 |
GO:2000279 | negative regulation of DNA biosynthetic process | 6.968600e-3 |
GO:0009890 | negative regulation of biosynthetic process | 7.033962e-3 |
GO:0044249 | cellular biosynthetic process | 7.126368e-3 |
GO:0019400 | alditol metabolic process | 7.126678e-3 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 7.170654e-3 |
GO:0048002 | antigen processing and presentation of peptide antigen | 7.258046e-3 |
GO:0042593 | glucose homeostasis | 7.340269e-3 |
GO:0072179 | nephric duct formation | 7.413169e-3 |
GO:0031325 | positive regulation of cellular metabolic process | 7.430493e-3 |
GO:0048522 | positive regulation of cellular process | 7.481413e-3 |
GO:0045923 | positive regulation of fatty acid metabolic process | 7.510124e-3 |
GO:0006369 | termination of RNA polymerase II transcription | 7.576394e-3 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 7.642691e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 7.642691e-3 |
GO:0006214 | thymidine catabolic process | 7.701490e-3 |
GO:0043000 | Golgi to plasma membrane CFTR protein transport | 7.797590e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 7.865201e-3 |
GO:0048807 | female genitalia morphogenesis | 7.940626e-3 |
GO:0006919 | activation of caspase activity | 7.961382e-3 |
GO:0009084 | glutamine family amino acid biosynthetic process | 7.990738e-3 |
GO:0034623 | cellular macromolecular complex disassembly | 8.060292e-3 |
GO:0019369 | arachidonic acid metabolic process | 8.083589e-3 |
GO:0072164 | mesonephric tubule development | 8.083589e-3 |
GO:0035881 | amacrine cell differentiation | 8.184603e-3 |
GO:0001525 | angiogenesis | 8.219771e-3 |
GO:0035058 | nonmotile primary cilium assembly | 8.360825e-3 |
GO:0010604 | positive regulation of macromolecule metabolic process | 8.369151e-3 |
GO:0007155 | cell adhesion | 8.412869e-3 |
GO:0034260 | negative regulation of GTPase activity | 8.482331e-3 |
GO:0046849 | bone remodeling | 8.565743e-3 |
GO:0048598 | embryonic morphogenesis | 8.570392e-3 |
GO:0016051 | carbohydrate biosynthetic process | 8.659360e-3 |
GO:0045059 | positive thymic T cell selection | 8.686899e-3 |
GO:0034391 | regulation of smooth muscle cell apoptosis | 8.686899e-3 |
GO:0002456 | T cell mediated immunity | 8.686899e-3 |
GO:0006638 | neutral lipid metabolic process | 8.720764e-3 |
GO:0006641 | triglyceride metabolic process | 8.727361e-3 |
GO:0051607 | defense response to virus | 8.741570e-3 |
GO:0019433 | triglyceride catabolic process | 8.794762e-3 |
GO:0016337 | cell-cell adhesion | 8.798014e-3 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 8.848224e-3 |
GO:0006355 | regulation of transcription, DNA-dependent | 9.064092e-3 |
GO:0060662 | salivary gland cavitation | 9.124355e-3 |
GO:0009112 | nucleobase metabolic process | 9.197385e-3 |
GO:0016571 | histone methylation | 9.234736e-3 |
GO:0007509 | mesoderm migration involved in gastrulation | 9.271747e-3 |
GO:0060684 | epithelial-mesenchymal cell signaling | 9.321771e-3 |
GO:0007172 | signal complex assembly | 9.321771e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 9.389184e-3 |
GO:0030282 | bone mineralization | 9.446386e-3 |
GO:0030262 | apoptotic nuclear change | 9.446386e-3 |
GO:0031497 | chromatin assembly | 9.450699e-3 |
GO:0009743 | response to carbohydrate stimulus | 9.453558e-3 |
GO:0090288 | negative regulation of cellular response to growth factor stimulus | 9.659252e-3 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | 9.739093e-3 |
GO:0006212 | uracil catabolic process | 9.739093e-3 |
GO:0006210 | thymine catabolic process | 9.739093e-3 |
GO:0014031 | mesenchymal cell development | 9.760884e-3 |
GO:0008380 | RNA splicing | 9.764143e-3 |
GO:0051149 | positive regulation of muscle cell differentiation | 9.918751e-3 |
GO:0034405 | response to fluid shear stress | 9.927888e-3 |
GO:0006569 | tryptophan catabolic process | 9.964021e-3 |
GO:0043017 | positive regulation of lymphotoxin A biosynthetic process | 9.980791e-3 |
GO:0010085 | polarity specification of proximal/distal axis | 9.980791e-3 |
GO:0048793 | pronephros development | 1.021530e-2 |
GO:0001955 | blood vessel maturation | 1.021530e-2 |
GO:0006568 | tryptophan metabolic process | 1.035776e-2 |
GO:0051186 | cofactor metabolic process | 1.055353e-2 |
GO:0001569 | patterning of blood vessels | 1.057845e-2 |
GO:0032984 | macromolecular complex disassembly | 1.065019e-2 |
GO:0002666 | positive regulation of T cell tolerance induction | 1.079288e-2 |
GO:2000191 | regulation of fatty acid transport | 1.082600e-2 |
GO:0031214 | biomineral tissue development | 1.087097e-2 |
GO:0006333 | chromatin assembly or disassembly | 1.117263e-2 |
GO:0006351 | transcription, DNA-dependent | 1.118439e-2 |
GO:0021629 | olfactory nerve structural organization | 1.145376e-2 |
GO:0046825 | regulation of protein export from nucleus | 1.164325e-2 |
GO:0090208 | positive regulation of triglyceride metabolic process | 1.170041e-2 |
GO:0010171 | body morphogenesis | 1.173215e-2 |
GO:0048754 | branching morphogenesis of a tube | 1.176726e-2 |
GO:0032713 | negative regulation of interleukin-4 production | 1.182510e-2 |
GO:0032890 | regulation of organic acid transport | 1.188886e-2 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 1.193332e-2 |
GO:0006807 | nitrogen compound metabolic process | 1.200921e-2 |
GO:0034505 | tooth mineralization | 1.204634e-2 |
GO:0046635 | positive regulation of alpha-beta T cell activation | 1.223217e-2 |
GO:0048015 | phosphatidylinositol-mediated signaling | 1.224797e-2 |
GO:0046464 | acylglycerol catabolic process | 1.224904e-2 |
GO:0031175 | neuron projection development | 1.225276e-2 |
GO:0046341 | CDP-diacylglycerol metabolic process | 1.240181e-2 |
GO:0044335 | canonical Wnt receptor signaling pathway involved in neural crest cell differentiation | 1.240181e-2 |
GO:0048643 | positive regulation of skeletal muscle tissue development | 1.246389e-2 |
GO:0009058 | biosynthetic process | 1.252760e-2 |
GO:0050848 | regulation of calcium-mediated signaling | 1.253382e-2 |
GO:0010660 | regulation of muscle cell apoptosis | 1.258341e-2 |
GO:0019859 | thymine metabolic process | 1.268719e-2 |
GO:0006625 | protein targeting to peroxisome | 1.272657e-2 |
GO:0010940 | positive regulation of necrotic cell death | 1.277611e-2 |
GO:0050870 | positive regulation of T cell activation | 1.319013e-2 |
GO:0006729 | tetrahydrobiopterin biosynthetic process | 1.321074e-2 |
GO:0060021 | palate development | 1.324442e-2 |
GO:0010629 | negative regulation of gene expression | 1.324485e-2 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.332576e-2 |
GO:0000904 | cell morphogenesis involved in differentiation | 1.348317e-2 |
GO:0006662 | glycerol ether metabolic process | 1.364105e-2 |
GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 1.369862e-2 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.371158e-2 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 1.378569e-2 |
GO:0002070 | epithelial cell maturation | 1.392490e-2 |
GO:0032933 | SREBP-mediated signaling pathway | 1.412955e-2 |
GO:0071396 | cellular response to lipid | 1.432543e-2 |
GO:0060466 | activation of meiosis involved in egg activation | 1.467441e-2 |
GO:0006284 | base-excision repair | 1.469609e-2 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 1.477569e-2 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 1.487469e-2 |
GO:0032653 | regulation of interleukin-10 production | 1.488337e-2 |
GO:2000179 | positive regulation of neural precursor cell proliferation | 1.488337e-2 |
GO:0007409 | axonogenesis | 1.492691e-2 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.499691e-2 |
GO:0043574 | peroxisomal transport | 1.502115e-2 |
GO:2000344 | positive regulation of acrosome reaction | 1.504285e-2 |
GO:0042666 | negative regulation of ectodermal cell fate specification | 1.505147e-2 |
GO:0006145 | purine base catabolic process | 1.537362e-2 |
GO:0030838 | positive regulation of actin filament polymerization | 1.551728e-2 |
GO:0000723 | telomere maintenance | 1.562624e-2 |
GO:0050954 | sensory perception of mechanical stimulus | 1.573823e-2 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 1.576559e-2 |
GO:0035814 | negative regulation of renal sodium excretion | 1.601591e-2 |
GO:0051153 | regulation of striated muscle cell differentiation | 1.614986e-2 |
GO:0046112 | nucleobase biosynthetic process | 1.626960e-2 |
GO:0051239 | regulation of multicellular organismal process | 1.629596e-2 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 1.651690e-2 |
GO:0046887 | positive regulation of hormone secretion | 1.657059e-2 |
GO:0060986 | endocrine hormone secretion | 1.659255e-2 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 1.682757e-2 |
GO:0046104 | thymidine metabolic process | 1.682757e-2 |
GO:0006196 | AMP catabolic process | 1.682757e-2 |
GO:0046146 | tetrahydrobiopterin metabolic process | 1.702758e-2 |
GO:0009059 | macromolecule biosynthetic process | 1.717292e-2 |
GO:0048812 | neuron projection morphogenesis | 1.748192e-2 |
GO:2000369 | regulation of clathrin-mediated endocytosis | 1.758238e-2 |
GO:0001957 | intramembranous ossification | 1.770129e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 7.456868e-14 |
GO:0035912 | dorsal aorta morphogenesis | 1.215436e-11 |
GO:0030038 | contractile actin filament bundle assembly | 1.215436e-11 |
GO:0010735 | positive regulation of transcription via serum response element binding | 4.380530e-10 |
GO:0033561 | regulation of water loss via skin | 8.470993e-10 |
GO:0001947 | heart looping | 1.203516e-9 |
GO:0009952 | anterior/posterior pattern specification | 1.334835e-9 |
GO:0032367 | intracellular cholesterol transport | 1.494682e-9 |
GO:0009948 | anterior/posterior axis specification | 3.026831e-9 |
GO:0032078 | negative regulation of endodeoxyribonuclease activity | 3.903155e-9 |
GO:0006922 | cleavage of lamin | 3.903155e-9 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 4.534695e-9 |
GO:0090009 | primitive streak formation | 5.326569e-9 |
GO:2000142 | regulation of transcription initiation, DNA-dependent | 5.861916e-9 |
GO:0032365 | intracellular lipid transport | 6.784613e-9 |
GO:0035050 | embryonic heart tube development | 7.486455e-9 |
GO:0016226 | iron-sulfur cluster assembly | 9.800665e-9 |
GO:0001704 | formation of primary germ layer | 1.100450e-8 |
GO:0042663 | regulation of endodermal cell fate specification | 1.188939e-8 |
GO:0007369 | gastrulation | 1.211287e-8 |
GO:0001711 | endodermal cell fate commitment | 2.584023e-8 |
GO:0001763 | morphogenesis of a branching structure | 2.760055e-8 |
GO:0055013 | cardiac muscle cell development | 4.282045e-8 |
GO:0010669 | epithelial structure maintenance | 4.423929e-8 |
GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway | 5.763376e-8 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 6.766397e-8 |
GO:0032074 | negative regulation of nuclease activity | 8.940276e-8 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 8.940276e-8 |
GO:0055006 | cardiac cell development | 8.984188e-8 |
GO:0003002 | regionalization | 1.030646e-7 |
GO:0048332 | mesoderm morphogenesis | 1.167761e-7 |
GO:0032071 | regulation of endodeoxyribonuclease activity | 1.291829e-7 |
GO:0035907 | dorsal aorta development | 1.480436e-7 |
GO:0060218 | hemopoietic stem cell differentiation | 1.704137e-7 |
GO:0035855 | megakaryocyte development | 1.955660e-7 |
GO:0035987 | endodermal cell differentiation | 2.037021e-7 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 2.415538e-7 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 3.024491e-7 |
GO:0032070 | regulation of deoxyribonuclease activity | 3.371409e-7 |
GO:2000121 | regulation of removal of superoxide radicals | 4.216744e-7 |
GO:0035909 | aorta morphogenesis | 4.928872e-7 |
GO:0007368 | determination of left/right symmetry | 5.124333e-7 |
GO:0035590 | purinergic nucleotide receptor signaling pathway | 5.157907e-7 |
GO:0048754 | branching morphogenesis of a tube | 5.684963e-7 |
GO:0039020 | pronephric nephron tubule development | 5.822482e-7 |
GO:0035565 | regulation of pronephros size | 5.822482e-7 |
GO:0009799 | specification of symmetry | 7.192697e-7 |
GO:0007569 | cell aging | 7.313373e-7 |
GO:0072181 | mesonephric duct formation | 7.485349e-7 |
GO:0035588 | G-protein coupled purinergic receptor signaling pathway | 8.742702e-7 |
GO:0007498 | mesoderm development | 8.760181e-7 |
GO:0035282 | segmentation | 9.114188e-7 |
GO:0009082 | branched chain family amino acid biosynthetic process | 1.575832e-6 |
GO:0021761 | limbic system development | 1.662136e-6 |
GO:0060931 | sinoatrial node cell development | 1.799973e-6 |
GO:0003167 | atrioventricular bundle cell differentiation | 1.799973e-6 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 2.032313e-6 |
GO:0002042 | cell migration involved in sprouting angiogenesis | 2.073489e-6 |
GO:0035904 | aorta development | 2.132876e-6 |
GO:0035886 | vascular smooth muscle cell differentiation | 2.427353e-6 |
GO:0007389 | pattern specification process | 2.539330e-6 |
GO:0055094 | response to lipoprotein stimulus | 2.721776e-6 |
GO:0008595 | anterior/posterior axis specification, embryo | 3.129874e-6 |
GO:0009798 | axis specification | 3.283485e-6 |
GO:0060921 | sinoatrial node cell differentiation | 3.756460e-6 |
GO:0007141 | male meiosis I | 3.827726e-6 |
GO:0021988 | olfactory lobe development | 3.939780e-6 |
GO:0070830 | tight junction assembly | 4.131266e-6 |
GO:0003151 | outflow tract morphogenesis | 4.296811e-6 |
GO:0038007 | netrin-activated signaling pathway | 4.551057e-6 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 4.551057e-6 |
GO:0035587 | purinergic receptor signaling pathway | 4.617211e-6 |
GO:0060932 | His-Purkinje system cell differentiation | 4.701455e-6 |
GO:0060926 | pacemaker cell development | 4.701455e-6 |
GO:0006437 | tyrosyl-tRNA aminoacylation | 5.101834e-6 |
GO:0055007 | cardiac muscle cell differentiation | 5.365698e-6 |
GO:0046884 | follicle-stimulating hormone secretion | 5.830981e-6 |
GO:0032275 | luteinizing hormone secretion | 5.830981e-6 |
GO:0061138 | morphogenesis of a branching epithelium | 5.998560e-6 |
GO:0061017 | hepatoblast differentiation | 6.273734e-6 |
GO:0048806 | genitalia development | 6.290556e-6 |
GO:0001714 | endodermal cell fate specification | 6.709423e-6 |
GO:0003163 | sinoatrial node development | 7.929345e-6 |
GO:0060920 | pacemaker cell differentiation | 8.751028e-6 |
GO:0060976 | coronary vasculature development | 1.058151e-5 |
GO:0001825 | blastocyst formation | 1.097593e-5 |
GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.156461e-5 |
GO:0060537 | muscle tissue development | 1.339260e-5 |
GO:0090136 | epithelial cell-cell adhesion | 1.376939e-5 |
GO:0010159 | specification of organ position | 1.525093e-5 |
GO:0002011 | morphogenesis of an epithelial sheet | 1.584209e-5 |
GO:0021772 | olfactory bulb development | 1.719056e-5 |
GO:0042659 | regulation of cell fate specification | 1.731421e-5 |
GO:0048821 | erythrocyte development | 1.785087e-5 |
GO:0035564 | regulation of kidney size | 1.812565e-5 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 1.829787e-5 |
GO:0007568 | aging | 2.130895e-5 |
GO:0090398 | cellular senescence | 2.299526e-5 |
GO:0060292 | long term synaptic depression | 2.309098e-5 |
GO:0050891 | multicellular organismal water homeostasis | 2.309098e-5 |
GO:0003206 | cardiac chamber morphogenesis | 2.338665e-5 |
GO:0048863 | stem cell differentiation | 2.399864e-5 |
GO:0003309 | type B pancreatic cell differentiation | 2.940986e-5 |
GO:0060923 | cardiac muscle cell fate commitment | 2.946050e-5 |
GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 2.946050e-5 |
GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 3.180702e-5 |
GO:0035239 | tube morphogenesis | 3.184453e-5 |
GO:0060347 | heart trabecula formation | 3.306541e-5 |
GO:0030219 | megakaryocyte differentiation | 3.306541e-5 |
GO:0048738 | cardiac muscle tissue development | 3.507606e-5 |
GO:0061384 | heart trabecular morphogenesis | 3.536587e-5 |
GO:0001826 | inner cell mass cell differentiation | 3.697719e-5 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 3.884013e-5 |
GO:0031018 | endocrine pancreas development | 4.416399e-5 |
GO:0072180 | mesonephric duct morphogenesis | 4.536694e-5 |
GO:0001706 | endoderm formation | 4.808263e-5 |
GO:0001756 | somitogenesis | 5.895505e-5 |
GO:0043297 | apical junction assembly | 6.034684e-5 |
GO:0060907 | positive regulation of macrophage cytokine production | 6.047153e-5 |
GO:0010453 | regulation of cell fate commitment | 6.171004e-5 |
GO:0030539 | male genitalia development | 6.564406e-5 |
GO:0055003 | cardiac myofibril assembly | 6.614037e-5 |
GO:0090322 | regulation of superoxide metabolic process | 6.703153e-5 |
GO:0014706 | striated muscle tissue development | 7.111359e-5 |
GO:0003205 | cardiac chamber development | 7.545885e-5 |
GO:0003166 | bundle of His development | 7.842515e-5 |
GO:0072095 | regulation of branch elongation involved in ureteric bud branching | 7.956489e-5 |
GO:0060688 | regulation of morphogenesis of a branching structure | 8.117990e-5 |
GO:2000334 | positive regulation of blood microparticle formation | 8.123282e-5 |
GO:0046546 | development of primary male sexual characteristics | 8.124292e-5 |
GO:0055001 | muscle cell development | 8.160559e-5 |
GO:0001702 | gastrulation with mouth forming second | 8.385125e-5 |
GO:0007140 | male meiosis | 8.748924e-5 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 9.080849e-5 |
GO:0048729 | tissue morphogenesis | 9.203067e-5 |
GO:0060677 | ureteric bud elongation | 9.451684e-5 |
GO:0060411 | cardiac septum morphogenesis | 9.910317e-5 |
GO:0010470 | regulation of gastrulation | 9.949128e-5 |
GO:0045766 | positive regulation of angiogenesis | 1.164251e-4 |
GO:0019368 | fatty acid elongation, unsaturated fatty acid | 1.271282e-4 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.359544e-4 |
GO:0021750 | vestibular nucleus development | 1.364581e-4 |
GO:0021679 | cerebellar molecular layer development | 1.364581e-4 |
GO:0021590 | cerebellum maturation | 1.364581e-4 |
GO:0046716 | muscle cell homeostasis | 1.387204e-4 |
GO:0060005 | vestibular reflex | 1.413587e-4 |
GO:0003350 | pulmonary myocardium development | 1.413587e-4 |
GO:0032908 | regulation of transforming growth factor beta1 production | 1.424204e-4 |
GO:0010817 | regulation of hormone levels | 1.429198e-4 |
GO:0000578 | embryonic axis specification | 1.437859e-4 |
GO:0007254 | JNK cascade | 1.509434e-4 |
GO:0032069 | regulation of nuclease activity | 1.525415e-4 |
GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | 1.564798e-4 |
GO:0060911 | cardiac cell fate commitment | 1.591329e-4 |
GO:0045987 | positive regulation of smooth muscle contraction | 1.634124e-4 |
GO:0035051 | cardiac cell differentiation | 1.674160e-4 |
GO:0046879 | hormone secretion | 1.697281e-4 |
GO:0071447 | cellular response to hydroperoxide | 1.724149e-4 |
GO:0015911 | plasma membrane long-chain fatty acid transport | 1.724149e-4 |
GO:0072172 | mesonephric tubule formation | 1.769236e-4 |
GO:0009083 | branched chain family amino acid catabolic process | 1.773585e-4 |
GO:0001707 | mesoderm formation | 1.805781e-4 |
GO:0030220 | platelet formation | 1.857144e-4 |
GO:0023061 | signal release | 1.858800e-4 |
GO:0043000 | Golgi to plasma membrane CFTR protein transport | 1.893368e-4 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 1.927455e-4 |
GO:0060414 | aorta smooth muscle tissue morphogenesis | 2.041703e-4 |
GO:0044283 | small molecule biosynthetic process | 2.149963e-4 |
GO:0035117 | embryonic arm morphogenesis | 2.187363e-4 |
GO:0060100 | positive regulation of phagocytosis, engulfment | 2.385024e-4 |
GO:0046661 | male sex differentiation | 2.531039e-4 |
GO:0046902 | regulation of mitochondrial membrane permeability | 2.574086e-4 |
GO:0010935 | regulation of macrophage cytokine production | 2.677487e-4 |
GO:0021766 | hippocampus development | 2.730154e-4 |
GO:0048793 | pronephros development | 2.862671e-4 |
GO:0043149 | stress fiber assembly | 2.894301e-4 |
GO:0021578 | hindbrain maturation | 2.915854e-4 |
GO:0051146 | striated muscle cell differentiation | 3.021660e-4 |
GO:0060841 | venous blood vessel development | 3.124989e-4 |
GO:2000108 | positive regulation of leukocyte apoptosis | 3.166517e-4 |
GO:0007492 | endoderm development | 3.252782e-4 |
GO:0042574 | retinal metabolic process | 3.253014e-4 |
GO:0030104 | water homeostasis | 3.370194e-4 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 3.526434e-4 |
GO:0071542 | dopaminergic neuron differentiation | 3.682345e-4 |
GO:0061053 | somite development | 3.708791e-4 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 3.898456e-4 |
GO:0060004 | reflex | 3.976547e-4 |
GO:0031098 | stress-activated protein kinase signaling cascade | 4.053076e-4 |
GO:0016567 | protein ubiquitination | 4.137705e-4 |
GO:0009880 | embryonic pattern specification | 4.215681e-4 |
GO:0002009 | morphogenesis of an epithelium | 4.249162e-4 |
GO:0032755 | positive regulation of interleukin-6 production | 4.479652e-4 |
GO:0014056 | regulation of acetylcholine secretion | 4.606273e-4 |
GO:0072177 | mesonephric duct development | 4.667947e-4 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 4.691261e-4 |
GO:0040007 | growth | 4.760712e-4 |
GO:0072171 | mesonephric tubule morphogenesis | 5.229349e-4 |
GO:2000648 | positive regulation of stem cell proliferation | 5.295336e-4 |
GO:0008340 | determination of adult lifespan | 5.365048e-4 |
GO:0043503 | skeletal muscle fiber adaptation | 5.445243e-4 |
GO:0060638 | mesenchymal-epithelial cell signaling | 5.550655e-4 |
GO:0030239 | myofibril assembly | 5.650216e-4 |
GO:0072091 | regulation of stem cell proliferation | 5.741330e-4 |
GO:0002040 | sprouting angiogenesis | 5.843486e-4 |
GO:0060562 | epithelial tube morphogenesis | 5.932975e-4 |
GO:0003161 | cardiac conduction system development | 6.001152e-4 |
GO:0002779 | antibacterial peptide secretion | 6.244548e-4 |
GO:0050434 | positive regulation of viral transcription | 6.344752e-4 |
GO:0048852 | diencephalon morphogenesis | 6.502601e-4 |
GO:0060596 | mammary placode formation | 6.510766e-4 |
GO:0055096 | low-density lipoprotein particle mediated signaling | 6.899249e-4 |
GO:0031334 | positive regulation of protein complex assembly | 6.935047e-4 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 7.002553e-4 |
GO:0030163 | protein catabolic process | 7.084560e-4 |
GO:0044257 | cellular protein catabolic process | 7.215050e-4 |
GO:0072179 | nephric duct formation | 7.219902e-4 |
GO:0061029 | eyelid development in camera-type eye | 7.226366e-4 |
GO:0001569 | patterning of blood vessels | 7.233250e-4 |
GO:0030497 | fatty acid elongation | 7.337280e-4 |
GO:0060788 | ectodermal placode formation | 8.068031e-4 |
GO:0006950 | response to stress | 8.407329e-4 |
GO:0060024 | rhythmic synaptic transmission | 8.608413e-4 |
GO:0048791 | calcium ion-dependent exocytosis of neurotransmitter | 8.829837e-4 |
GO:0031327 | negative regulation of cellular biosynthetic process | 8.904648e-4 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 9.012802e-4 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 9.012802e-4 |
GO:0000027 | ribosomal large subunit assembly | 9.317260e-4 |
GO:0016574 | histone ubiquitination | 9.470102e-4 |
GO:0045662 | negative regulation of myoblast differentiation | 9.857775e-4 |
GO:0070997 | neuron death | 9.857942e-4 |
GO:0060603 | mammary gland duct morphogenesis | 9.896460e-4 |
GO:0007493 | endodermal cell fate determination | 1.059591e-3 |
GO:0003279 | cardiac septum development | 1.078245e-3 |
GO:0009914 | hormone transport | 1.091276e-3 |
GO:0006633 | fatty acid biosynthetic process | 1.092542e-3 |
GO:0045165 | cell fate commitment | 1.097275e-3 |
GO:0009887 | organ morphogenesis | 1.127285e-3 |
GO:0006839 | mitochondrial transport | 1.205740e-3 |
GO:0071221 | cellular response to bacterial lipopeptide | 1.208698e-3 |
GO:0060437 | lung growth | 1.208698e-3 |
GO:0003148 | outflow tract septum morphogenesis | 1.231777e-3 |
GO:0061061 | muscle structure development | 1.277682e-3 |
GO:0007076 | mitotic chromosome condensation | 1.283194e-3 |
GO:0009890 | negative regulation of biosynthetic process | 1.305231e-3 |
GO:0003007 | heart morphogenesis | 1.317017e-3 |
GO:0007267 | cell-cell signaling | 1.336880e-3 |
GO:0031032 | actomyosin structure organization | 1.338147e-3 |
GO:0007548 | sex differentiation | 1.379690e-3 |
GO:0043534 | blood vessel endothelial cell migration | 1.395420e-3 |
GO:0046394 | carboxylic acid biosynthetic process | 1.407519e-3 |
GO:0048813 | dendrite morphogenesis | 1.422668e-3 |
GO:0051491 | positive regulation of filopodium assembly | 1.474569e-3 |
GO:0032446 | protein modification by small protein conjugation | 1.493250e-3 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 1.579650e-3 |
GO:0033344 | cholesterol efflux | 1.617355e-3 |
GO:0009615 | response to virus | 1.643795e-3 |
GO:0050881 | musculoskeletal movement | 1.682389e-3 |
GO:0007043 | cell-cell junction assembly | 1.721314e-3 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 1.743270e-3 |
GO:0045785 | positive regulation of cell adhesion | 1.799646e-3 |
GO:0042472 | inner ear morphogenesis | 1.802327e-3 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 1.803609e-3 |
GO:0007628 | adult walking behavior | 1.836024e-3 |
GO:0007006 | mitochondrial membrane organization | 1.836024e-3 |
GO:0014051 | gamma-aminobutyric acid secretion | 1.845981e-3 |
GO:0032274 | gonadotropin secretion | 1.894233e-3 |
GO:0051145 | smooth muscle cell differentiation | 1.938684e-3 |
GO:0051253 | negative regulation of RNA metabolic process | 2.012181e-3 |
GO:0061383 | trabecula morphogenesis | 2.052347e-3 |
GO:0051025 | negative regulation of immunoglobulin secretion | 2.200880e-3 |
GO:0009081 | branched chain family amino acid metabolic process | 2.210235e-3 |
GO:0045022 | early endosome to late endosome transport | 2.284612e-3 |
GO:0001829 | trophectodermal cell differentiation | 2.301505e-3 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.303562e-3 |
GO:0017004 | cytochrome complex assembly | 2.303562e-3 |
GO:0010811 | positive regulation of cell-substrate adhesion | 2.362818e-3 |
GO:0051354 | negative regulation of oxidoreductase activity | 2.373020e-3 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 2.422924e-3 |
GO:0042060 | wound healing | 2.505087e-3 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 2.511615e-3 |
GO:0030644 | cellular chloride ion homeostasis | 2.551568e-3 |
GO:0072078 | nephron tubule morphogenesis | 2.602224e-3 |
GO:0072178 | nephric duct morphogenesis | 2.653154e-3 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 2.654499e-3 |
GO:0030301 | cholesterol transport | 2.658042e-3 |
GO:0030193 | regulation of blood coagulation | 2.721332e-3 |
GO:0046782 | regulation of viral transcription | 2.730612e-3 |
GO:0035295 | tube development | 2.743105e-3 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.749917e-3 |
GO:0030534 | adult behavior | 2.786536e-3 |
GO:0060412 | ventricular septum morphogenesis | 2.812108e-3 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 2.812964e-3 |
GO:0045995 | regulation of embryonic development | 2.857834e-3 |
GO:0019835 | cytolysis | 2.877102e-3 |
GO:0009791 | post-embryonic development | 2.930505e-3 |
GO:0030194 | positive regulation of blood coagulation | 2.932236e-3 |
GO:0031175 | neuron projection development | 2.946790e-3 |
GO:0061350 | planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 2.961658e-3 |
GO:0060210 | metestrus | 2.961658e-3 |
GO:0061349 | planar cell polarity pathway involved in cardiac right atrium morphogenesis | 2.961658e-3 |
GO:0061354 | planar cell polarity pathway involved in pericardium morphogenesis | 2.961658e-3 |
GO:0061348 | planar cell polarity pathway involved in ventricular septum morphogenesis | 2.961658e-3 |
GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis | 2.961658e-3 |
GO:0042904 | 9-cis-retinoic acid biosynthetic process | 2.965476e-3 |
GO:0051402 | neuron apoptosis | 3.009044e-3 |
GO:0071634 | regulation of transforming growth factor beta production | 3.072849e-3 |
GO:0051188 | cofactor biosynthetic process | 3.110908e-3 |
GO:0070245 | positive regulation of thymocyte apoptosis | 3.129697e-3 |
GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin | 3.204032e-3 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 3.265526e-3 |
GO:0071223 | cellular response to lipoteichoic acid | 3.265526e-3 |
GO:0032909 | regulation of transforming growth factor beta2 production | 3.284077e-3 |
GO:0021952 | central nervous system projection neuron axonogenesis | 3.293357e-3 |
GO:0019941 | modification-dependent protein catabolic process | 3.303998e-3 |
GO:0060343 | trabecula formation | 3.325544e-3 |
GO:0043254 | regulation of protein complex assembly | 3.366117e-3 |
GO:0021543 | pallium development | 3.404593e-3 |
GO:0048145 | regulation of fibroblast proliferation | 3.422845e-3 |
GO:0030320 | cellular monovalent inorganic anion homeostasis | 3.423021e-3 |
GO:0043632 | modification-dependent macromolecule catabolic process | 3.425555e-3 |
GO:0061041 | regulation of wound healing | 3.456923e-3 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 3.488849e-3 |
GO:0045059 | positive thymic T cell selection | 3.525728e-3 |
GO:0000209 | protein polyubiquitination | 3.537301e-3 |
GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation | 3.585600e-3 |
GO:0032353 | negative regulation of hormone biosynthetic process | 3.585600e-3 |
GO:0070234 | positive regulation of T cell apoptosis | 3.684041e-3 |
GO:0007616 | long-term memory | 3.687432e-3 |
GO:0070848 | response to growth factor stimulus | 3.722375e-3 |
GO:0060067 | cervix development | 3.724398e-3 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 3.786216e-3 |
GO:0010498 | proteasomal protein catabolic process | 3.864483e-3 |
GO:0072176 | nephric duct development | 3.886865e-3 |
GO:0022603 | regulation of anatomical structure morphogenesis | 3.923395e-3 |
GO:0051489 | regulation of filopodium assembly | 3.940473e-3 |
GO:0006104 | succinyl-CoA metabolic process | 3.971447e-3 |
GO:0002826 | negative regulation of T-helper 1 type immune response | 3.971447e-3 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 4.040208e-3 |
GO:0043524 | negative regulation of neuron apoptosis | 4.048390e-3 |
GO:0015812 | gamma-aminobutyric acid transport | 4.104603e-3 |
GO:0007005 | mitochondrion organization | 4.179569e-3 |
GO:0048598 | embryonic morphogenesis | 4.234224e-3 |
GO:0060415 | muscle tissue morphogenesis | 4.272688e-3 |
GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis | 4.293392e-3 |
GO:0045040 | protein import into mitochondrial outer membrane | 4.293392e-3 |
GO:0002553 | histamine secretion by mast cell | 4.293392e-3 |
GO:0002741 | positive regulation of cytokine secretion involved in immune response | 4.293392e-3 |
GO:0048147 | negative regulation of fibroblast proliferation | 4.308075e-3 |
GO:0045933 | positive regulation of muscle contraction | 4.581965e-3 |
GO:0071635 | negative regulation of transforming growth factor beta production | 4.672086e-3 |
GO:0031324 | negative regulation of cellular metabolic process | 4.690840e-3 |
GO:0072164 | mesonephric tubule development | 4.709971e-3 |
GO:0055002 | striated muscle cell development | 4.719256e-3 |
GO:0001824 | blastocyst development | 4.784493e-3 |
GO:0007257 | activation of JUN kinase activity | 4.801491e-3 |
GO:0060743 | epithelial cell maturation involved in prostate gland development | 4.912288e-3 |
GO:0045014 | negative regulation of transcription by glucose | 4.912288e-3 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 4.962727e-3 |
GO:0048853 | forebrain morphogenesis | 5.009872e-3 |
GO:0030240 | skeletal muscle thin filament assembly | 5.009872e-3 |
GO:0048644 | muscle organ morphogenesis | 5.023643e-3 |
GO:0033554 | cellular response to stress | 5.082496e-3 |
GO:0030073 | insulin secretion | 5.219299e-3 |
GO:0002790 | peptide secretion | 5.345108e-3 |
GO:0009607 | response to biotic stimulus | 5.371506e-3 |
GO:0060560 | developmental growth involved in morphogenesis | 5.397675e-3 |
GO:0032472 | Golgi calcium ion transport | 5.418276e-3 |
GO:0032468 | Golgi calcium ion homeostasis | 5.418276e-3 |
GO:0030026 | cellular manganese ion homeostasis | 5.418276e-3 |
GO:0007032 | endosome organization | 5.516625e-3 |
GO:0043589 | skin morphogenesis | 5.518779e-3 |
GO:0042471 | ear morphogenesis | 5.567771e-3 |
GO:0048850 | hypophysis morphogenesis | 5.582263e-3 |
GO:0030540 | female genitalia development | 5.649790e-3 |
GO:0045765 | regulation of angiogenesis | 5.653860e-3 |
GO:0042362 | fat-soluble vitamin biosynthetic process | 5.960337e-3 |
GO:0030825 | positive regulation of cGMP metabolic process | 5.960337e-3 |
GO:0050820 | positive regulation of coagulation | 6.218460e-3 |
GO:0048468 | cell development | 6.257316e-3 |
GO:0034261 | negative regulation of Ras GTPase activity | 6.304399e-3 |
GO:0043032 | positive regulation of macrophage activation | 6.345309e-3 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 6.379581e-3 |
GO:0071158 | positive regulation of cell cycle arrest | 6.465751e-3 |
GO:0070232 | regulation of T cell apoptosis | 6.465751e-3 |
GO:0045214 | sarcomere organization | 6.483410e-3 |
GO:0030155 | regulation of cell adhesion | 6.581788e-3 |
GO:0048524 | positive regulation of viral reproduction | 6.651513e-3 |
GO:0060751 | branch elongation involved in mammary gland duct branching | 6.684869e-3 |
GO:0045216 | cell-cell junction organization | 6.745910e-3 |
GO:0044265 | cellular macromolecule catabolic process | 6.755355e-3 |
GO:0050818 | regulation of coagulation | 6.865289e-3 |
GO:0060592 | mammary gland formation | 6.955954e-3 |
GO:0021889 | olfactory bulb interneuron differentiation | 6.955954e-3 |
GO:0035695 | mitochondrion degradation by induced vacuole formation | 7.070043e-3 |
GO:0002309 | T cell proliferation involved in immune response | 7.079682e-3 |
GO:0046463 | acylglycerol biosynthetic process | 7.098739e-3 |
GO:0044249 | cellular biosynthetic process | 7.230463e-3 |
GO:0055088 | lipid homeostasis | 7.264506e-3 |
GO:0045137 | development of primary sexual characteristics | 7.354459e-3 |
GO:0034599 | cellular response to oxidative stress | 7.422480e-3 |
GO:0048844 | artery morphogenesis | 7.442002e-3 |
GO:0003310 | pancreatic A cell differentiation | 7.465399e-3 |
GO:0090403 | oxidative stress-induced premature senescence | 7.487539e-3 |
GO:0022029 | telencephalon cell migration | 7.639790e-3 |
GO:0060548 | negative regulation of cell death | 7.700471e-3 |
GO:0033630 | positive regulation of cell adhesion mediated by integrin | 7.738316e-3 |
GO:0051707 | response to other organism | 7.805481e-3 |
GO:2000484 | positive regulation of interleukin-8 secretion | 7.909014e-3 |
GO:0003344 | pericardium morphogenesis | 7.909014e-3 |
GO:0060986 | endocrine hormone secretion | 7.939945e-3 |
GO:0019244 | lactate biosynthetic process from pyruvate | 7.969741e-3 |
GO:0021990 | neural plate formation | 7.969741e-3 |
GO:0002003 | angiotensin maturation | 7.970630e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 7.970630e-3 |
GO:0048589 | developmental growth | 8.002433e-3 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 8.017707e-3 |
GO:0021548 | pons development | 8.017707e-3 |
GO:0001568 | blood vessel development | 8.113337e-3 |
GO:0031398 | positive regulation of protein ubiquitination | 8.200551e-3 |
GO:0030168 | platelet activation | 8.230687e-3 |
GO:0007263 | nitric oxide mediated signal transduction | 8.303632e-3 |
GO:0060340 | positive regulation of type I interferon-mediated signaling pathway | 8.344205e-3 |
GO:0060840 | artery development | 8.359276e-3 |
GO:0009110 | vitamin biosynthetic process | 8.467755e-3 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 8.559853e-3 |
GO:0042573 | retinoic acid metabolic process | 8.563678e-3 |
GO:2000106 | regulation of leukocyte apoptosis | 8.792881e-3 |
GO:0010458 | exit from mitosis | 8.793207e-3 |
GO:0000733 | DNA strand renaturation | 8.793207e-3 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 8.907396e-3 |
GO:0060575 | intestinal epithelial cell differentiation | 9.017852e-3 |
GO:0021537 | telencephalon development | 9.040620e-3 |
GO:0048752 | semicircular canal morphogenesis | 9.488366e-3 |
GO:0090037 | positive regulation of protein kinase C signaling cascade | 9.732993e-3 |
GO:0021885 | forebrain cell migration | 9.748911e-3 |
GO:0035115 | embryonic forelimb morphogenesis | 9.773283e-3 |
GO:0000038 | very long-chain fatty acid metabolic process | 9.861400e-3 |
GO:0046504 | glycerol ether biosynthetic process | 9.975492e-3 |
GO:0042221 | response to chemical stimulus | 1.005234e-2 |
GO:0010927 | cellular component assembly involved in morphogenesis | 1.005520e-2 |
GO:0048286 | lung alveolus development | 1.021931e-2 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.022394e-2 |
GO:0051890 | regulation of cardioblast differentiation | 1.022537e-2 |
GO:0014866 | skeletal myofibril assembly | 1.047950e-2 |
GO:0007127 | meiosis I | 1.078164e-2 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 1.083186e-2 |
GO:0070171 | negative regulation of tooth mineralization | 1.096113e-2 |
GO:0044268 | multicellular organismal protein metabolic process | 1.096113e-2 |
GO:0007420 | brain development | 1.100590e-2 |
GO:0070243 | regulation of thymocyte apoptosis | 1.104790e-2 |
GO:0051930 | regulation of sensory perception of pain | 1.126773e-2 |
GO:0010820 | positive regulation of T cell chemotaxis | 1.153486e-2 |
GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 1.171425e-2 |
GO:0043069 | negative regulation of programmed cell death | 1.175071e-2 |
GO:0046015 | regulation of transcription by glucose | 1.178188e-2 |
GO:0008333 | endosome to lysosome transport | 1.181507e-2 |
GO:2000406 | positive regulation of T cell migration | 1.189637e-2 |
GO:0021930 | cerebellar granule cell precursor proliferation | 1.205147e-2 |
GO:0032675 | regulation of interleukin-6 production | 1.222401e-2 |
GO:0043542 | endothelial cell migration | 1.229630e-2 |
GO:0043066 | negative regulation of apoptosis | 1.230852e-2 |
GO:0045658 | regulation of neutrophil differentiation | 1.232977e-2 |
GO:0050805 | negative regulation of synaptic transmission | 1.256614e-2 |
GO:0030857 | negative regulation of epithelial cell differentiation | 1.264608e-2 |
GO:0001894 | tissue homeostasis | 1.267683e-2 |
GO:0043506 | regulation of JUN kinase activity | 1.268709e-2 |
GO:0022612 | gland morphogenesis | 1.270489e-2 |
GO:0001954 | positive regulation of cell-matrix adhesion | 1.288693e-2 |
GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | 1.302420e-2 |
GO:0043501 | skeletal muscle adaptation | 1.302420e-2 |
GO:0009058 | biosynthetic process | 1.310365e-2 |
GO:0035249 | synaptic transmission, glutamatergic | 1.313096e-2 |
GO:0060443 | mammary gland morphogenesis | 1.326044e-2 |
GO:0072079 | nephron tubule formation | 1.326175e-2 |
GO:0060693 | regulation of branching involved in salivary gland morphogenesis | 1.326175e-2 |
GO:0001938 | positive regulation of endothelial cell proliferation | 1.330045e-2 |
GO:0006952 | defense response | 1.330218e-2 |
GO:0070170 | regulation of tooth mineralization | 1.346877e-2 |
GO:0003323 | type B pancreatic cell development | 1.346877e-2 |
GO:0007034 | vacuolar transport | 1.373891e-2 |
GO:0060425 | lung morphogenesis | 1.394735e-2 |
GO:0060686 | negative regulation of prostatic bud formation | 1.405998e-2 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 1.405998e-2 |
GO:0072028 | nephron morphogenesis | 1.406562e-2 |
GO:0043405 | regulation of MAP kinase activity | 1.406944e-2 |
GO:0019432 | triglyceride biosynthetic process | 1.421794e-2 |
GO:0021986 | habenula development | 1.436760e-2 |
GO:0000414 | regulation of histone H3-K36 methylation | 1.436760e-2 |
GO:0006626 | protein targeting to mitochondrion | 1.439977e-2 |
GO:0007596 | blood coagulation | 1.445613e-2 |
GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 1.450165e-2 |
GO:0007417 | central nervous system development | 1.462013e-2 |
GO:0051964 | negative regulation of synapse assembly | 1.466572e-2 |
GO:0051925 | regulation of calcium ion transport via voltage-gated calcium channel activity | 1.467586e-2 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.479806e-2 |
GO:0007599 | hemostasis | 1.521937e-2 |
GO:0034260 | negative regulation of GTPase activity | 1.528603e-2 |
GO:0006379 | mRNA cleavage | 1.528603e-2 |
GO:0010259 | multicellular organismal aging | 1.548104e-2 |